Correlation Between Genmab AS and CSL
Can any of the company-specific risk be diversified away by investing in both Genmab AS and CSL at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genmab AS and CSL into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genmab AS and CSL, you can compare the effects of market volatilities on Genmab AS and CSL and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genmab AS with a short position of CSL. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genmab AS and CSL.
Diversification Opportunities for Genmab AS and CSL
Pay attention - limited upside
The 3 months correlation between Genmab and CSL is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Genmab AS and CSL in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CSL and Genmab AS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genmab AS are associated (or correlated) with CSL. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CSL has no effect on the direction of Genmab AS i.e., Genmab AS and CSL go up and down completely randomly.
Pair Corralation between Genmab AS and CSL
If you would invest (100.00) in Genmab AS on January 25, 2024 and sell it today you would earn a total of 100.00 from holding Genmab AS or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Genmab AS vs. CSL
Performance |
Timeline |
Genmab AS |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
CSL |
Genmab AS and CSL Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Genmab AS and CSL
The main advantage of trading using opposite Genmab AS and CSL positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genmab AS position performs unexpectedly, CSL can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CSL will offset losses from the drop in CSL's long position.Genmab AS vs. Valens | Genmab AS vs. MACOM Technology Solutions | Genmab AS vs. Analog Devices | Genmab AS vs. Ultra Clean Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Transaction History View history of all your transactions and understand their impact on performance |